BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Neurology

UniXell Secures US FDA Clearance for Off-the-Shelf Parkinson’s Cell Therapy, Advancing Dual-China-US Clinical Development

UniXell Biotechnology Co., Ltd. ("UniXell") has secured Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for UX-DA...

June 25, 2026 | News

Teijin Pharma Limited and Merz Therapeutics GmbH Win Japanese Approval for XEOMIN® in Cervical Dystonia and Blepharospasm

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurolog...

June 23, 2026 | News

Mabwell Advances Alpha Synuclein PET Tracer Into Phase I Strengthening Early Diagnosis Of Neurodegenerative Disorders

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that 18F-FD4 (R&D code: SST0...

April 16, 2026 | News

Neurocrine Biosciences To Acquire Soleno Therapeutics For $2.9 Billion To Strengthen Rare Disease Portfolio

VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and...

April 07, 2026 | News

Neurophet Partners With ALZ NET To Advance AI Driven Imaging In Alzheimer’s Care

Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key solutions Collaboration expected to ...

March 31, 2026 | News

Celosia Therapeutics Initiates Phase 1b Trial Of CTx1000 Targeting TDP 43 In ALS

CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS Celosia Therapeutics, an Australian biotech company developing advanced gen...

March 25, 2026 | News

CellCarta And Biofidelity Expand Global Partnership With Exclusive Aspyre Lung Deployment In Clinical Trials

CellCarta and Biofidelity announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settin...

March 20, 2026 | News

Australian Researchers Launch Clinical Trial Exploring Hyperbaric Oxygen Therapy For High Grade Glioma

Australian researchers from Southern Cross University (SCU) and the Melbourne Integrative Oncology Group (MIOG) will launch a clinical study investigating ...

March 17, 2026 | News

Telix Resubmits US NDA For Pixclara PET Imaging Agent Targeting Glioma Diagnosis

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces the resubmission of a New Drug Application (NDA) to the United States (U.S.) Food ...

March 17, 2026 | News

Unixell Biotech Secures US FDA IND Clearance For iPSC Derived Epilepsy Cell Therapy

Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational N...

March 16, 2026 | News

Vimgreen Pharmaceuticals Secures China IND Approval For VG081821 In NASH Clinical Development

Vimgreen Pharmaceuticals, a leading innovator in adenosine signaling modulation, announced the approval of its Investigational New Drug (IND) application f...

March 16, 2026 | News

Curatis Partners With Neupharma To Advance Corticorelin Development For Brain Tumour Related Edema In Japan

Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developi...

March 12, 2026 | News

Codex Genetics And C2N Diagnostics Partner To Expand Alzheimer’s Blood Test Access In Hong Kong

Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, today announces a strategic collaboration with C2N Diagnostics (C2N), a...

March 11, 2026 | News

BrainXell Launches Human iPSC Derived Sensory Neurons Platform To Advance Pain And Ion Channel Research

BrainXell announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineer...

March 06, 2026 | News

Stay Connected